HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Huang, Z. Articles by Wang, H. Search for Related Content PubMed PubMed Citation Articles by Huang, Z. Articles by Wang, H. Related Collections Cardiac - other

Ann Thorac Surg 2003;76:1609-1613
© 2003 The Society of Thoracic Surgeons

---

Original article: cardiovascular

Primary cardiac valve tumors: early and late results of surgical treatment in 10 patients

^a Department of Cardiovascular Surgery, Cardiovascular Institute, Fu Wai Hospital, Chinese Academy of Medical Science, Peking Union Medical College, Beijing, China
^b Department of Pathology, Cardiovascular Institute, Fu Wai Hospital, Chinese Academy of Medical Science, Peking Union Medical College, Beijing, China

Accepted for publication May 28, 2003.

^* Address reprint requests to Dr Huang, Department of Cardiovascular Surgery, Cardiovascular Institute, Fu Wai Hospital, A 167 Beilishi Rd, Fuchengmenwai, Beijing 100037, China.
e-mail: huangzhixiong{at}fwxw.org

BACKGROUND: Our goal was to study the clinical characteristics of primary valve tumors and the late surgical results of their resection.

METHODS: We reviewed our clinical experience with the surgical treatment of ten primary valve tumors at Fu Wai Hospital over the past 19 years. During that time, cardiac valve tumors accounted for 2.65% of all primary cardiac tumors at our hospital, and the incidence of primary valve tumors was roughly one in 4,000 cardiac operations. There were 5 male and 5 female patients aged 2 to 66 years (mean age, 30.1 years). The clinical presentation included exertional dyspnea in 7 patients, neurological symptoms in 2, and cyanosis at rest in 1 patient. The diagnosis was established by preoperative echocardiography in 8 patients, and in the other 2, it was confirmed by the findings at operation. All of the tumors were resected. Eight of the ten tumors were benign, and two were malignant.

RESULTS: All patients survived the operation and recovered uneventfully. Late outcomes were known for all patients. There were three late deaths. One patient with a benign tricuspid valve tumor died 2 months postoperatively of an electrolyte disorder. The other 2 patients with a malignant mitral valve tumor died within 1 year postoperatively. The 7 survivors, all with a benign valve tumor, were followed for an average of 5.7 years (range, 8 months to 19 years), and all were in functional class I. Exercise tolerance improved to normal levels. The latest follow-up echocardiograms showed no evidence of local recurrence in any patient.

CONCLUSIONS: Excellent early and late surgical results can be obtained in patients with benign valve tumors. The prognosis for patients with a malignant valve tumor is poor.

This article has been cited by other articles:

				G. Shanmugam and I. Colquhoun Left Atrial Malignant Mesenchymoma -- Emergency Resection and Mitral Replacement Asian Cardiovasc Thorac Ann, August 1, 2007; 15(4): e46 - e48. [Abstract] [Full Text] [PDF]

				G. Shanmugam Primary cardiac sarcoma. Eur. J. Cardiothorac. Surg., June 1, 2006; 29(6): 925 - 932. [Abstract] [Full Text] [PDF]